|
Strong growth momentum in the first half of 2015
2015.08.17
|
|---|
|
- Sales increased by 32.8% and operating profit increased by 34.0% compared to the same period last year - Poised to receive the 10 Million Dollar Export Tower Award - Bio division started supplying vaccines to domestic animal vaccine manufacturers from April
Daehan New Pharm experienced robust growth in the first half of 2015.
Cumulative sales for H1 2015 reached 44.095 billion KRW, a 32.8% increase year-over-year, while operating profit rose 34.0% to 4.820 billion KRW. The operating profit margin continued to improve, reaching 10.9%, marking a sustained 15-quarter streak of growth since Q4 2011.
Alongside growth, the company reduced accounts receivable by 869 million KRW and borrowings by 598 million KRW compared to the end of 2014. This resulted in 28.3 fewer days in sales receivables turnover and a 7.9 percentage point decrease in the debt-to-sales ratio to 46.8%, indicating strengthened financial stability.
Daehan New Pharm has actively implemented operational innovations such as building databases for value-based sales per clinic, disseminating successful case studies, and enhancing sales skills through role-playing. These initiatives are aimed at increasing customer value and talent development, showing positive results in parts.
Exports from the overseas business division also showed remarkable growth, with H1 2015 export revenues rising 25.0% year-over-year to 6.068 billion KRW. From July 2014 to June 2015, export sales exceeded 10 million USD, ensuring receipt of the export tower award.
The bio division is progressing well with its mid-to-long-term plans, having started regular vaccine supplies to domestic animal vaccine manufacturers since April. Other companies are testing Daehan New Pharm’s vaccines for productivity, safety, and cost-effectiveness to apply them in their production lines.
In celebration of its 30th anniversary, Daehan New Pharm engaged its employees in reaffirming their commitment to future growth as a trusted and respected company, while concretizing visions and plans for sustainable long-term development. |


Home